In this episode, we discuss the progression of COVID-19 treatments over the past year and what may lie ahead with HIVMA Chair Rajesh Gandhi, MD, FIDSA of Harvard University and IDSA Fellow Adarsh Bhimraj, MD, FIDSA of the Cleveland Clinic.
*This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000574-01-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.